{
    "paper_id": "31509643bc6af1026fdfb272aa7abe4f29aa6f2b",
    "metadata": {
        "title": "Journal Pre-proof Cardiac Surgery and the COVID-19 Pandemic: What We Know, What We Don't Know, and What We Need to Do Cardiac Surgery and the COVID-19 Pandemic: What We Know, What We Don't Know, and What We Need to Do 2 3 Corresponding Author",
        "authors": [
            {
                "first": "Faisal",
                "middle": [
                    "G"
                ],
                "last": "Bakaeen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Cleveland Clinic",
                    "location": {
                        "settlement": "Heart, Cleveland",
                        "region": "Vascular, Ohio"
                    }
                },
                "email": "bakaeef@ccf.org."
            },
            {
                "first": "A",
                "middle": [
                    "Marc"
                ],
                "last": "Gillinov",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Cleveland Clinic",
                    "location": {
                        "settlement": "Heart, Cleveland",
                        "region": "Vascular, Ohio"
                    }
                },
                "email": ""
            },
            {
                "first": "Eric",
                "middle": [
                    "E"
                ],
                "last": "Roselli",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Cleveland Clinic",
                    "location": {
                        "settlement": "Heart, Cleveland",
                        "region": "Vascular, Ohio"
                    }
                },
                "email": ""
            },
            {
                "first": "Joanna",
                "middle": [],
                "last": "Chikwe",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Marc",
                "middle": [
                    "R"
                ],
                "last": "Moon",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Washington University",
                    "location": {
                        "addrLine": "14 Barnes-Jewish Hospital",
                        "settlement": "St. Louis",
                        "region": "Missouri"
                    }
                },
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "H"
                ],
                "last": "Adams",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Joseph",
                "middle": [
                    "S"
                ],
                "last": "Coselli",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Baylor College of Medicine",
                    "location": {
                        "settlement": "Houston",
                        "region": "Texas"
                    }
                },
                "email": ""
            },
            {
                "first": "Joseph",
                "middle": [
                    "A"
                ],
                "last": "Dearani",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Mayo Clinic",
                    "location": {
                        "settlement": "Rochester",
                        "region": "Minnesota"
                    }
                },
                "email": ""
            },
            {
                "first": "Lars",
                "middle": [
                    "G"
                ],
                "last": "Svensson",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Cleveland Clinic",
                    "location": {
                        "settlement": "Heart, Cleveland",
                        "region": "Vascular, Ohio"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "As it unfolds, the COVID-19 pandemic is proving to be the seminal challenge of our 50 generation. The human and economic toll has been felt across the globe, with no 51 proven effective treatment or vaccine on the horizon. 1 To impede viral transmission, states, all non-emergency cardiac surgery was suspended early in the response to the 96 rising curve of the population infected with COVID-19.",
            "cite_spans": [
                {
                    "start": 223,
                    "end": 224,
                    "text": "1",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "The role of ECMO in treating critically ill COVID-19 patients is evolving, but mortality is For surgeons who get infected, when can they safely return to work? Should we wait 180 until they test negative for the virus or is there a more robust parameter? Some have speculated that the reluctance to be at hospitals during the pandemic and 182 the resultant delay in care could create a pool of patients who will enter the hospital in 183 more critical condition. For example, will there be a resurgence of mechanical 184 myocardial infarction complications such as papillary muscle ruptures with acute mitral 185 regurgitation, post-infarction ventricular septal defects, and free-wall ruptures, or more 186 patients presenting late with acute aortic syndromes? Of course, a bigger concern is 187 that many of these patients will never get care at all and die at home from potentially 188 treatable cardiovascular conditions. This concern is borne out, at least partly, in recent testing, rigorous contact tracing, and antibody testing? How useful is the latter and will it 208 be a reliable indicator of immunity? What is the risk of reinfection? Once states begin to 209 reopen for business, will there be a second wave of the pandemic, and will the surge be 210 just as bad as or even worse than the initial one? How long will it be before an effective and enduring relationships for safe and effective patient care. The benefits of this 281 collaboration will become more apparent when the pandemic is over.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "97"
        },
        {
            "text": "As we rise to the challenge and face this crisis with hope and determination, one 283 ponders how cardiac surgery might change. One thing that will definitely change is how 284 we manage our resources, from simple face masks to more complex safety equipment.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "282"
        },
        {
            "text": "Good stewardship of not only material, but also human assets, will be a priority. Looking 286 forward, nothing will be taken for granted, and contingencies will be part of any strategic 287 planning. Leadership, resiliency, and innovation that are in the genetic blueprint of the 288 cardiac surgeon will enable us to prevail and ensure a secure and bright future for our 289 specialty and for the well-being of our patients. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "285"
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Review of emerging pharmacotherapy for the treatment of coronavirus disease 299 2019",
            "authors": [],
            "year": 2020,
            "venue": "Pharmacotherapy",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/phar.2398"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Canadian Society of Cardiac Surgeons. Cardiac surgery in Canada during the 306 COVID-19 pandemic: a guidance statement from the Canadian Society of",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Cardiac Surgeons",
            "authors": [],
            "year": 2020,
            "venue": "Can J Cardiol",
            "volume": "",
            "issn": "20",
            "pages": "30323--30331",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "COVID-19: crisis management in congenital heart surgery",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Cl",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Ann Thorac",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Adult cardiac surgery during the COVID-19 pandemic: a 314 tiered patient triage guidance statement",
            "authors": [],
            "year": 2020,
            "venue": "Thoracic Surgeons COVID-19 Taskforce and the Workforce for Adult Cardiac 313 and Vascular Surgery",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.athoracsur.2020.04.003"
                ]
            }
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Act as a Unit: the Story of Cleveland Clinic",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Jd Clough",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Studer",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Rebuilder of Hearts, Dies at 99. The 320 New York Times",
            "authors": [
                {
                    "first": "Lawrence",
                    "middle": [
                        "K"
                    ],
                    "last": "Altman",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Michael Debakey",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "The variety of cardiovascular presentations of COVID-19. Circulation",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "323",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1161/CIRCULATIONAHA.120.047164"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Inside a major New York City hospital system battling coronavirus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Italian Society 329 for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 330 outbreak and its impact on hospitals in Italy: the model of cardiac surgery",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bonalumi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Di Mauro",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Garatti",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Barili",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Gerosa",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Parolari",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Prognosis when 334 using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-335 19 patients in China: a retrospective case series. Crit Care",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xianyu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "X"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "24",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1186/s13054-020-2840-8"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Initial ELSO guidance document: ECMO for COVID-19 patients with severe 339 cardiopulmonary failure",
            "authors": [],
            "year": 2020,
            "venue": "ASAIO J",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "34010.1097/MAT.0000000000001173"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "15 477 Characteristics of Health Care Personnel with COVID-19 -344 United States",
            "authors": [],
            "year": 2009,
            "venue": "",
            "volume": "69",
            "issn": "",
            "pages": "2020--2039",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "The characteristics of household transmission of COVID-19",
            "authors": [],
            "year": null,
            "venue": "Clin Infect",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Household tansmission of SARS-351",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Response of cardiac surgery units to the COVID-19 pandemic: an internationally-355 based quantitative survey and expert recommendations",
            "authors": [],
            "year": 2020,
            "venue": "JAMA Cardiol",
            "volume": "356",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Mortality while waiting for aortic valve replacement",
            "authors": [],
            "year": 2014,
            "venue": "Ann Thorac Surg",
            "volume": "359",
            "issn": "",
            "pages": "1570--1571",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Adverse events while awaiting myocardial revascularization: 362 a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Head",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "R"
                    ],
                    "last": "Da Costa",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Beumer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "G"
                    ],
                    "last": "Stefanini",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Alfonso",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Clemmensen",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Eur J Cardiothorac Surg",
            "volume": "52",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Reduction in ST-segment elevation cardiac catheterization laboratory activations 366 in the United States during COVID-19 pandemic",
            "authors": [],
            "year": 2009,
            "venue": "J Am Coll Cardiol",
            "volume": "367",
            "issn": "20",
            "pages": "34913--34918",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jacc.2020.04.011"
                ]
            }
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "A high-volume thoracic surgery division into the storm of 370 the COVID-19 pandemic",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Maurizi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Rendina",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Thorac Surg",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Clinical course 373 of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges 374 in diagnosis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Braithwaite",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thorac Cardiovasc Surg",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Predictive mathematical models of the 376",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "P"
                    ],
                    "last": "Jewell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Lewnard",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Jewell",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "COVID-19 pandemic: underlying principles and value of projections",
            "authors": [],
            "year": null,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Clinical characteristics and 379 outcomes of patients undergoing surgeries during the incubation period of 380 COVID-19 infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mei",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "EClinicalMedicine",
            "volume": "381",
            "issn": "24",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "38610.1097/ACM.0000000000003418"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "52 local authorities and governments around the world have imposed aggressive 53 containment measures by quarantining initial COVID-19 clusters and in many cases 54 instituting a complete nationwide lockdown. 55 Healthcare systems were hit by a tsunami of patients and their resources stretched to 56 breaking points. Shortages of personal protective equipment (PPE), sanitation products, 57 ventilators, and ICU beds have been widely reported. To preserve PPE and prepare for 58 the potential surge of COVID-19 patients to U.S. hospitals, the Center for Medicare and 59 Medicaid Services asked for deferral of nonessential procedures and surgeries. 2 60 Professional societies and experts in various fields have put forward guidance 61 recommendations regarding triaging patients and resource utilization during this 62 crisis. 3-5 63 Surgeons are natural leaders when it comes to responding to disasters during both 64 peace and wartime. The founders of both Cleveland Clinic and Mayo Clinic were 65 inspired to found their institutions by experiences and observations made during 66 wartime collaboration in the delivery of emergency care. 6 Dr. Michael DeBakey was 67 tasked by the country's leadership to document the history of medicine and surgery of 68 the army after WWII. This work led him to conceive of the idea of Mobile Army Surgical 69 Hospital (MASH) units as a solution to many of the problems encountered by the army's 70 medical care of soldiers during the war. It was an offshoot of what he did with Dr.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "98 uniformly high and little is known about the long-term lung function of survivors. 11,12 The 99 Extracorporeal Life Support Organization recommends selective use of ECMO in 100 COVID-19 patients and advises against starting new ECMO centers for the sole 101 purpose of treating COVID-19. 12 Recognizing the dismal outlook for patients with 102 COVID-19 myocarditis and severe pulmonary involvement, many centers have elected 103 not to institute ECMO in COVID-19 patients with these complications. Ethical 104 considerations come into play not only in decision-making about patient care and the 105 role of ECMO, but also in day-to-day cardiac surgery practice during these uncharted 106 times. 107 When caring for COVID-19 patients, it is important to remember the real risks 108 associated with the viral infection. Healthcare workers are estimated to account for 19% 109 of cases reported to the CDC, and more than half reported contact with a COVID-19 110 patient only in a healthcare setting. 13 Most healthcare workers with COVID-19 were not 111 hospitalized; however, severe adverse outcomes, including 27 (0.3%-0.6%) deaths, 112 have been reported. 13 In addition, families of caregivers can also be at increased risk, 113 with estimates of household transmission of COVID-19 in China at 16%-30%, 14,15 and 114 that is likely an underestimate of the actual risk. These findings underscore the 115 importance of protecting the health of all caregivers. Such realities, COVID-19 threat preoccupies the world, it is easy to overlook the long-standing, 119 ongoing cardiovascular disease burden. According to a survey conducted in March 120 2020, among 60 centers from around the world participating in a randomized trial of 121 multiarterial grafting in coronary artery bypass surgery, there was median reduction in 122 cardiac surgery case volume of 50%-75%, a figure that correlated with the number of 123 local COVID-19 cases. Most centers (57%) restricted their cardiac surgery activity to 124 urgent/emergency cases, and 5% cancelled all cardiac surgery; 32% of the centers 125 relocated cardiac surgical personnel to other care areas. The majority of the centers 126 suspended or modified research activity. 16 127 But deaths of patients with severe aortic stenosis awaiting valve replacement, with 128 aortic aneurysms awaiting repair, or with coronary artery disease awaiting 129 revascularization serve as powerful reminders that cardiac surgery is often not 130 \"elective,\" and many patients have life-threatening cardiovascular conditions. 17,18 To 131 compound this problem, alarming data is emerging to suggest that patients are avoiding 132 medical care during the COVID-19 pandemic to minimize potential exposure. One study 133 estimated a 38% reduction in U.S. cardiac catheterization laboratory STEMI activations, 134 similar to the 40% reduction observed in Spain. 19 Access of care issues, STEMI 135 misdiagnosis, and increased use of pharmacological reperfusion due to COVID-19 are 136 other possible but less likely explanations for this observation.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "same time, there has been a remarkable example of successful continuation of 138 thoracic oncologic care at a busy center in Italy during the surge. There was a 22% 139 reduction of case volume, but the outcomes were encouraging, with no patients140 converting to COVID-19 positive during follow-up and no postoperative readmissions 141 related to COVID-19. This accomplishment was achieved with rigorous protocols. 20 142 Nevertheless, data from Wuhan showed that of 11 patients undergoing thoracic surgery 143 who postoperatively were found to be COVID-19 positive, 3 (27%) died. 21 144 What We Don't Know 145 As cardiac surgeons ponder the next steps in dealing with the pandemic and its 146 aftermath, they encounter the universal challenge of accurately predicting the future. 147 Current COVID-19 models are fraught with limitations to account for multiple unknown 148 factors, such as accuracy of diagnostic tests, waning of immunity, possible reinfection, 149 and the possibility that important variables like degree of social distancing might change 150 over time. 22 Predictive models for large countries such as the United States become 151 even more complex because of heterogeneous subepidemics in local areas. 22 152 To date, we know little about the safety of performing cardiac surgery during the 153 pandemic. Although it varies from one center to another, risk of COVID-19 exposure 154 and infection in the hospital and the extent and impact of diversion of personnel and 155 resources away from cardiac surgery is unknown. Cardiovascular intensivists from 156 some of our units have almost uniformly been redeployed to care for COVID-19 157 patients, further challenging current team performance. A long-term decrease in surgical 158 volume may blunt surgical skills and team effectiveness.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "non-urgent patients during the height of the pandemic may be a high-risk160    proposition. In a study of 34 patients who underwent noncardiac surgical procedures at161    Wuhan hospitals and then tested COVID-19 positive, 15 (44%) needed ICU care, and 162 mortality was 20.5%. 23 All the patients developed pneumonia, and ICU admissions were 163 more prevalent in patients undergoing complex procedures. As previously mentioned, 164 mortality of 27% was reported in another study from a thoracic surgery unit in Wuhan. 21165There were no cardiac surgery patients in these cohorts, but one can speculate that the166 prevalence of hypertension and other pre-existing comorbidities compounded by 167 cardiopulmonary bypass and the need for mechanical ventilation might add to the 168 physiologic insult and risk in such patients. 169 The risk of performing emergency cardiac surgery on known symptomatic COVID-19 170 positive patients is unknown, but mortality would be expected to be higher than under 171 normal circumstances. We also do not know \"the safe time\" to operate on a patient who 172 has recovered from the infection or whether there is a risk of COVID-19 reactivation. 173 Although the risk of exposure and infection in healthcare personnel is well 174 documented, 13 the specific risk to cardiac surgeons is unknown. Obvious sources of 175 exposure include aerosol from ventilators, respiratory treatments, chest tube air leaks, 176 and electrocautery. Insufflation used in endoscopic saphenous vein harvesting also 177 presents an aerosolization risk. Reoperations are particularly risky because of the 178 potential for parenchymal lung injury during sternal re-entry and mediastinal dissection.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "189 reports of deaths in the United States exceeding what is historically expected even after 190 accounting for COVID-19 attributable deaths. 191 Another important issue is a surge in cardiac demand due to the backlog of cancelled or 192 postponed cases. While some cardiac centers may dial up to pre-pandemic levels or 193 beyond, other cardiac programs may not survive the disruptions and system attrition 194 caused by the pandemic. 195 COVID-19 will also cost the global economy several trillion dollars. 24 The financial 196 impact of the pandemic on healthcare systems is unclear at this point, but COVID-19 197 will be a financial stress test that reveals vulnerabilities. 25 Moody's Investors Service, a 198 bond credit-rating agency, downgraded its financial outlook for not-for-profit and public 199 hospitals in the United States from stable to negative in mid-March 2020. 25 Hospitals 200 with strong operating cash-flow margins and sufficient cash on hand will fare better than 201 those without it. The Coronavirus Aid, Relief, and Economic Security (CARES) Act was 202 recently passed by Congress, and additional recovery packages may be on the way, but 203 this is a short-term fix and will become insufficient at the current level of funding. Sadly, 204 layoffs, furloughs, and pay cuts are occurring, with the risk of eroding our response to 205 the pandemic and lowering morale among cardiovascular healthcare workers. 206 Many other questions remain unanswered: How soon can states begin large-scale 207",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "211 treatment and vaccine become available? Will there be threats from new viral 212 pandemics or other natural or man-made disasters? All patients undergoing cardiac 213 surgery should have COVID-19 virus testing immediately before surgery, but how 214 should we manage those with a positive test? Future investigations will provide some 215 answers and additional clarity.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "We Need to Do and the Road to Recovery 217 It is important to emphasize three key realities: First, this is a dynamic crisis; things are 218 moving rapidly and not necessarily in a predictable direction. Second, different regions 219 are affected to different extents and are at various time points along the course of the 220 pandemic. As we write this document, most states have not reached the peak of the 221 epidemiologic curve, and some may not experience a distinct peak. Third, the capacity 222 and preparedness of healthcare systems will vary by location. Because of this 223 variability, there is no one-size-fits-all list of recommendations about what cardiac 224 surgeons need to do. It is difficult, if not impossible, to provide \"guideline\" documents, 225 because evidence-based medicine related to this pandemic is not possible at the 226 present time due to paucity of data. Consequently, many published manuscripts on 227 COVID-19 to date have provided \"guidance\" considerations. These guidance 228 documents are largely determined by geographic area, local government 229 recommendations, hospital protocols and resources, and personnel and staffing issues.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "It is also important to emphasize that these recommendations are continuously evolving231    and changing. With this information in mind, there are certain guiding principles that we 232 will highlight and share.233    Our core mission remains to care for our patients and provide the best possible cardiac234 care. Obviously, there are competing priorities. That said, decisions about delaying 235 treatment should not be based on disease entities per se, but rather on the severity of 236 illness and chances of successful treatment. Resources should be allocated based on 237 specific protocols and criteria, irrespective of whether the need is related to COVID-19 238 or an unrelated illness.239Triage and delays may be inevitable for now and at some locations more than others,240 but hopefully few patients with a potentially curable cardiac disease will suffer because 241 of the COVID-19 season. This message may be misunderstood or misinterpreted 242 unless cardiac surgeons and others in cardiovascular medicine unite and deliver it to 243 decision-makers and to the public. This can be done through education, advocacy, and 244 outreach. But first, we must ensure and demonstrate safety.245 To safely care for our patients, exposure to COVID-19 should be minimized and 246 adequate resources should be in place. As states and hospitals ramp up their testing 247 capabilities, particularly with rapid testing, all patients should be tested. COVID-19 248 positive cases will be delayed except for emergency situations, with surgery performed 249 12 in dedicated operating rooms and recovery taking place in isolated units. Antibody 250 testing can help with staffing assignments and with weighing risks for patients and 251 caregivers. Safety protocols should be in place to ensure proper use of PPEs and to 252 handle possible exposures. 253 Another aspect of safety is ensuring good surgical outcomes despite the pandemic. It is 254 important for cardiac programs to track their case volumes, case mix, risk of COVID-19 255 infection, and outcomes in real time and share them with their team members, patients, 256 and colleagues. This will dispel fears and instill confidence that will bring patients back 257 for life-saving procedures. Poor outcomes related to suboptimal infection control or 258 preventable surgical complications are not acceptable. 259 Patient and caregiver education and support are key elements to effectively fight the 260 pandemic and achieve optimal recovery. Cardiac surgeons should be there to support 261 their patients, their coworkers, each other, their families, and communities, and 262 reciprocation will naturally follow. Technology will allow us to connect on a wider scale 263 to spread and share accurate information instead of misinformation. 264 Going back to business as usual is a distant event at this point in time. Resource 265 shortages are to be expected, with supply chain disruptions and resource diversion and 266 reallocation. However, the decision regarding when and how to reopen or ratchet up 267 cardiac surgery and interventional procedures should not be financially driven, but 268 based on clear safety and capacity metrics (Figure 1). 269 13 Ideally, one should strive to keep cardiac teams intact as we persevere through this 270 storm. Plans should be put in place to bring back team members who were reassigned 271 and to hire and train new members as needed. Smart and flexible scheduling will help 272 facilitate maintenance of sharp skills while reducing potential exposure risk and allowing 273 time for members to take care of themselves and their families. Telemedicine will likely 274 transform the elective consultative practice in many centers, and adaptive workflows 275 and optimized patient care pathways will save precious hospital resources. 276 Some programs may have to outsource their cardiac operations on a temporary or 277 permanent basis. But this is an important time to communicate and collaborate, share 278 information and resources, and volunteer to help some programs recover. The same 279 applies for educational and training programs. This pandemic can help us build valuable280",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "regurgitation; AS: Aortic stenosis; CAD: Coronary artery disease; LV: Left 294 ventricular; MR: Mitral regurgitation; MS: Mitral stenosis.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Edward Churchill, who was at the time not only Chief of Surgery at Massachusetts General Hospital in civilian life, but had spent time as Chief Consultant to the North African and Mediterranean theaters. During the Korean War, MASH units stationed doctors closer to the front lines and improved the survival of wounded soldiers; this became a model for modern-day civilian on-site disaster medical response. 7 Cardiac surgeons have now been thrust into the frontlines in the fight against the elusive enemy: COVID-19. This document summarizes key elements of the pandemic as it pertains to cardiac surgery. We start with what we know about the current state of affairs, then address 80 uncertainties and gaps in our knowledge. We focus on what we need to do as cardiac surgeons to lead the preparation for the next phase of the pandemic and the eventual transition back to normalcy.What We KnowMany COVID-19 manifestations will require cardiac surgical intervention. 8 From instituting extracorporeal membrane oxygenation (ECMO) and other forms of mechanical circulatory support to managing infected immunosuppressed cardiothoracic transplant patients, cardiac surgical expertise is required. In addition, cardiac surgery programs possess infrastructures and resources that are in critical demand to care for many hospitalized COVID patients. Therefore, by necessity, resources have been diverted away from cardiac surgery, and in many instances cardiac units have been repurposed as COVID-19 units, some of which are actually run by cardiac surgeons who leverage their critical care experience and leadership. 9 In Italy's Lombardy region, units forming \"the hub\" for the 16 other closed units.10  In New York and many other",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}